BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19720951)

  • 1. Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome?
    Glasser SP; Basile JN; Lackland DT
    Hypertension; 2009 Nov; 54(5):954-5. PubMed ID: 19720951
    [No Abstract]   [Full Text] [Related]  

  • 2. Home blood pressure as a cardiovascular outcome predictor: it's time to take this method seriously.
    Stergiou GS; Siontis KC; Ioannidis JP
    Hypertension; 2010 Jun; 55(6):1301-3. PubMed ID: 20385967
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension risk prediction: an important but complicated assessment.
    Lackland DT
    Hypertension; 2010 Jun; 55(6):1304-5. PubMed ID: 20439819
    [No Abstract]   [Full Text] [Related]  

  • 4. [Difference in blood pressure measured in the office and out of office].
    Kuwajima I
    Nihon Rinsho; 2008 Aug; 66(8):1531-6. PubMed ID: 18700553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension treatment: how important is consistency of effect?
    Sica DA
    Hypertension; 2007 Aug; 50(2):287-8. PubMed ID: 17606859
    [No Abstract]   [Full Text] [Related]  

  • 6. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
    Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
    J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant Hypertension: Trials and Tribulations.
    George MJ; Marks DJB; Rezk T; Breckenridge R; Sofat R; Martin J; MacAllister R; Touyz RM; Staessen JA; Bursztyn M; Lappin D; Barigou M; Hingorani A
    Hypertension; 2018 May; 71(5):772-780. PubMed ID: 29610269
    [No Abstract]   [Full Text] [Related]  

  • 8. When the clinical trials raise more questions than answers: blood pressure controversy beyond the TRANSCEND results.
    Barrios V; Escobar C; Echarri R; Calderon A
    J Clin Hypertens (Greenwich); 2009 Mar; 11(3):159-60. PubMed ID: 19302430
    [No Abstract]   [Full Text] [Related]  

  • 9. Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study.
    Cardoso CRL; Salles GF
    J Am Heart Assoc; 2020 Sep; 9(17):e017634. PubMed ID: 32851922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
    JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why Is Out-of-Office Blood Pressure Measurement Needed?
    Parati G; Omboni S; Bilo G
    Hypertension; 2009 Aug; 54(2):181-7. PubMed ID: 19581514
    [No Abstract]   [Full Text] [Related]  

  • 13. Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring.
    Verdecchia P; Angeli F; Mazzotta G; Gentile G; Reboldi G
    Hypertension; 2009 Aug; 54(2):188-95. PubMed ID: 19581513
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of cardiovascular risk and choice of antihypertensive therapy.
    Kannel WB; Vasan RS
    Curr Hypertens Rep; 2004 Oct; 6(5):346-51. PubMed ID: 15341685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
    Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
    Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Medication Treatment of Pediatric Hypertension: A Retrospective Cohort Study.
    Kaelber DC; Liu W; Ross M; Localio AR; Leon JB; Pace WD; Wasserman RC; Fiks AG;
    Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term risk in subjects with white-coat hypertension.
    Obara T; Ohkubo T; Imai Y
    Hypertension; 2009 Nov; 54(5):e133; author reply e134. PubMed ID: 19786645
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recommendations for the management of patients with severe arterial hypertension. Commission IV. Cardiovascular Diseases].
    Plouin PF; Fiessinger JN;
    Bull Acad Natl Med; 2012 Oct; 196(7):1423-7. PubMed ID: 23815023
    [No Abstract]   [Full Text] [Related]  

  • 19. [MAPA and stratification of cardiovascular risk in hypertense patients in primary care].
    Gijón Conde MT; Rodríguez Martín-Millanes C; Jones Dougan S; Pitillas Robledo I
    Aten Primaria; 2006 Oct; 38(7):415-6. PubMed ID: 17173820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):146-8. PubMed ID: 17679828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.